Analysts lowered/revised BILL price forecast after Q2 results. Revenue beat estimates, adjusted EPS exceeded consensus. Full-year outlook raised.
Latest Ratings for BILL
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 2022 | Oppenheimer | Maintains | Outperform | |
| Feb 2022 | Keybanc | Maintains | Overweight | |
| Feb 2022 | Keybanc | Maintains | Overweight |
